A computational evaluation of FDA medicines' ability to inhibit hypoxia-inducible factor prolyl hydroxylase-2 (PHD-2) for acute respiratory distress syndrome.
Jaikanth ChandrasekaranJayasudha BalasubramaniamPublished in: Structural chemistry (2022)
The online version contains supplementary material available at 10.1007/s11224-022-02012-z.